A nano-disperse ferritin-core mimetic that efficiently corrects anemia without luminal iron redox activity

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 7, 2014, Pages 1529-1538

  Powell, Jonathan J ^a   Bruggraber, Sylvaine F A ^a   Faria, Nuno ^a   Poots, Lynsey K ^a   Hondow, Nicole ^b   Pennycook, Timothy J ^c,d   Latunde Dada, Gladys O ^e   Simpson, Robert J ^e   Brown, Andy P ^b   Pereira, Dora I A ^a  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c DARESBURY LABORATORY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bioavailability; Ferrihydrite; Iron deficiency anemia; Iron oxide; Oral iron

Indexed keywords

BIOCHEMISTRY; FREE RADICALS; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; PRECIPITATION (CHEMICAL); REDOX REACTIONS; SULFUR COMPOUNDS;

BIOAVAILABILITY; FERRIHYDRITES; FREE RADICAL GENERATION; GASTROINTESTINAL UPTAKES; IRON DEFICIENCY; POLYMERIC STRUCTURES; PRIMARY PARTICLE SIZE; SYNTHETIC ANALOGUES;

IRON OXIDES;

FERRIC HYDROXIDE; FERRIC ION; FERROUS ION; FERROUS SULFATE; NANOCARRIER; TARTARIC ACID; TARTARIC ACID DERIVATIVE; TARTRATE MODIFIED NANODISPERSE FERRIHYDRITE; UNCLASSIFIED DRUG; FERRITIN; IRON; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG BIOAVAILABILITY; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON METABOLISM; MALE; MOLECULAR STABILITY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; REDUCTION; ANEMIA; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; SCANNING TRANSMISSION ELECTRON MICROSCOPY;

ANEMIA; ANIMALS; FERRITINS; IRON; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; NANOPARTICLES; OXIDATION-REDUCTION;

EID: 84908005215     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.12.011     Document Type: Article

References (73)

1. De Benoist B., McLean E., Egli I., Cogswell M. Worldwide prevalence of anaemia 1993-2005 2008, World Health Organization, Geneva, Switzerland.
2. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360(9343):1347-1360.
3. WHO The World Health Report. Reducing risks, promoting healthy life 2002, World Health Organization, Geneva, Switzerland.
4. Stoltzfus R.J. Iron deficiency: global prevalence and consequences. Food Nutr Bull 2003 Dec, 24(4 Suppl):S99-S103.
5. Adamson E.A., Bailey G.R., Richards N., Wilson H. Prevalence of anaemia in an inner city primary school population. Arch Dis Child 2008, 93(5):453.
6. Barroso F., Allard S., Kahan B.C., Connolly C., Smethurst H., Choo L., et al. Prevalence of maternal anaemia and its predictors: a multi-centre study. Eur J Obstet Gynecol Reprod Biol 2011 Nov, 159(1):99-105.
7. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006, 367(9505):133-143.
8. Dostal A., Chassard C., Hilty F.M., Zimmermann M.B., Jaeggi T., Rossi S., et al. Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr 2012, 142(2):271-277.
9. Werner T., Wagner S.J., Martinez I., Walter J., Chang J.S., Clavel T., et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011, 60(3):325-333.
10. Carrier J., Aghdassi E., Cullen J., Allard J.P. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 2002, 132(10):3146-3150.
11. Navas-Carretero S., Sarria B., Perez-Granados A.M., Schoppen S., Izquierdo-Pulido M., Vaquero M.P. A comparative study of iron bioavailability from cocoa supplemented with ferric pyrophosphate or ferrous fumarate in rats. Ann Nutr Metab 2007, 51(3):204-207.
12. Moretti D., Zimmermann M.B., Wegmuller R., Walczyk T., Zeder C., Hurrell R.F. Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr 2006, 83(3):632-638.
13. Davidsson L., Kastenmayer P., Szajewska H., Hurrell R.F., Barclay D. Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. Am J Clin Nutr 2000, 71(6):1597-1602.
14. Zimmermann M.B., Biebinger R., Egli I., Zeder C., Hurrell R.F. Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals. Br J Nutr 2011, 105(8):1245-1250.
15. Seril D.N., Liao J., Ho K.L., Warsi A., Yang C.S., Yang G.Y. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002, 47(6):1266-1278.
16. Radulescu S., Brookes M.J., Salgueiro P., Ridgway R.A., McGhee E., Anderson K., et al. Luminal iron levels govern intestinal tumorigenesis after apc loss in vivo. Cell Rep 2012, 2(2):270-282.
17. Jin F., Frohman C., Thannhauser T.W., Welch R.M., Glahn R.P. Effects of ascorbic acid, phytic acid and tannic acid on iron bioavailability from reconstituted ferritin measured by an in vitro digestion-Caco-2 cell model. Br J Nutr 2009, 101(7):972-981.
18. Lonnerdal B., Bryant A., Liu X., Theil E.C. Iron absorption from soybean ferritin in nonanemic women. Am J Clin Nutr 2006, 83(1):103-107.
19. Zhang L., Fischer W., Pippel E., Hause G., Brandsch M., Knez M. Receptor-mediated cellular uptake of nanoparticles: a switchable delivery system. Small (Weinheim an der Bergstrasse, Germany) 2011, 7(11):1538-1541.
20. Pan Y.H., Sader K., Powell J.J., Bleloch A., Gass M., Trinick J., et al. 3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images. J Struct Biol 2009, 166(1):22-31.
21. Wang Z., Li C., Ellenburg M., Soistman E., Ruble J., Wright B., et al. Structure of human ferritin L chain. Acta Crystallogr 2006, 62(Pt 7):800-806.
22. Barron V., Torrent J., Michel F.M. Critical evaluation of the revised akdalaite model for ferrihydrite-discussion. Am Mineral 2012, 97(1):253-254.
23. Drits V.A., Sakharov B.A., Salyn A.L., Manceau A. Structural model for ferrihydrite. Clay Miner 1993, 28(2):185-207.
24. Janney D.E., Cowley J.M., Buseck P.R. Transmission electron microscopy of synthetic 2-and 6-line ferrihydrite. Clay Clay Miner 2000, 48(1):111-119.
25. Michel F.M., Ehm L., Antao S.M., Lee P.L., Chupas P.J., Liu G., et al. The structure of ferrihydrite, a nanocrystalline material. Science 2007, 316(5832):1726-1729.
26. Paktunc D., Manceau A., Dutrizac J. Incorporation of Ge in ferrihydrite: implications for the structure of ferrihydrite. American Mineralogist 2013, 98(5-6):848-858.
27. Pan Y.H., Vaughan G., Brydson R., Bleloch A., Gass M., Sader K., et al. Electron-beam-induced reduction of Fe(3+) in iron phosphate dihydrate, ferrihydrite, haemosiderin and ferritin as revealed by electron energy-loss spectroscopy. Ultramicroscopy 2010, 110(8):1020-1032.
28. Johnson J.L., Cannon M., Watt R.K., Frankel R.B., Watt G.D. Forming the phosphate layer in reconstituted horse spleen ferritin and the role of phosphate in promoting core surface redox reactions. Biochemistry 1999, 38(20):6706-6713.
29. Lopez-Castro J.D., Delgado J.J., Perez-Omil J.A., Galvez N., Cuesta R., Watt R.K., et al. A new approach to the ferritin iron core growth: influence of the H/L ratio on the core shape. Dalton Trans 2012, 41(4):1320-1324.
30. Bejjani S., Pullakhandam R., Punjal R., Nair K.M. Gastric digestion of pea ferritin and modulation of its iron bioavailability by ascorbic and phytic acids in caco-2 cells. World J Gastroenterol 2007, 13(14):2083-2088.
31. Kalgaonkar S., Lonnerdal B. Receptor-mediated uptake of ferritin-bound iron by human intestinal Caco-2 cells. J Nutr Biochem 2009, 20(4):304-311.
32. Hoppler M., Schonbachler A., Meile L., Hurrell R.F., Walczyk T. Ferritin-iron is released during boiling and in vitro gastric digestion. J Nutr 2008, 138(5):878-884.
33. Kidane T.Z., Sauble E., Linder M.C. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 2006, 291(3):C445-C455.
34. Masuda H., Ishimaru Y., Aung M.S., Kobayashi T., Kakei Y., Takahashi M., et al. Iron biofortification in rice by the introduction of multiple genes involved in iron nutrition. Sci Rep 2012, 2:543.
35. Murgia I., Arosio P., Tarantino D., Soave C. Biofortification for combating 'hidden hunger' for iron. Trends Plant Sci 2012, 17(1):47-55.
36. Sperotto R.A., Ricachenevsky F.K., Waldow Vde A., Fett J.P. Iron biofortification in rice: it's a long way to the top. Plant Sci 2012, 190:24-39.
37. Stein A.J., Meenakshi J.V., Qaim M., Nestel P., Sachdev H.P., Bhutta Z.A. Potential impacts of iron biofortification in India. Soc Sci Med 2008, 66(8):1797-1808.
38. Powell J, Bruggraber S, Faria N, Pereira D, inventors. Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation. U.K. patent WO/2008/096130 2008 06.02.2008.
39. Cornell R.M., Schwertmann U. Influence of organic-anions on the crystallization of ferrihydrite. Clay Clay Miner 1979, 27(6):402-410.
40. Raja K.B., Jafri S.E., Dickson D., Acebron A., Cremonesi P., Fossati G., et al. Involvement of iron (ferric) reduction in the iron absorption mechanism of a trivalent iron-protein complex (iron protein succinylate). Pharmacol Toxicol 2000, 87(3):108-115.
41. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123(11):1939-1951.
42. Hilty F.M., Teleki A., Krumeich F., Buchel R., Hurrell R.F., Pratsinis S.E., et al. Development and optimization of iron- and zinc-containing nanostructured powders for nutritional applications. Nanotechnology 2009, 20(47):475101.
43. Jambor J.L., Dutrizac J.E. Occurrence and constitution of natural and synthetic ferrihydrite, a widespread iron oxyhydroxide. Chem Rev 1998, 98(7):2549-2586.
44. Russell J.D. Infrared spectroscopy of ferrihydrite-evidence for the presence of structural hydroxyl-groups. Clay Miner 1979, 14(2):109-114.
45. Cornell R.L., Schwertmann U. The iron oxides: structure, preparation, reactions, occurrences and uses 2003, Wiley-VCH, Weinham. 2nd ed.
46. Pan Y. Electron microscopy study of mineral cores in ferritin and haemosiderin 2007, University of Leeds, Leeds.
47. Pan Y., Brown A., Brydson R., Warley A., Li A., Powell J. Electron beam damage studies of synthetic 6-line ferrihydrite and ferritin molecule cores within a human liver biopsy. Micron 2006, 37(5):403-411.
48. Martell A.E., Smith R.M., Motekaitis R.J. NIST critically selected stability constants of metal complexes database version 8.0 2004, Gaithersburg, National Institute of Standards and Technology.
49. Timberlake C.F. Iron-tartrate complexes. J Chem Soc 1964, 1229-1240.
50. Galloway R., McGuire J. Determinants of compliance with iron supplementation: supplies, side effects, or psychology?. Soc Sci Med 1994, 39(3):381-390.
51. Hyder S.M., Persson L.A., Chowdhury A.M., Ekstrom E.C. Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr 2002, 20(2):175-179.
52. Lund E.K., Wharf S.G., Fairweather-Tait S.J., Johnson I.T. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 1999, 69(2):250-255.
53. Wegmuller R., Zimmermann M.B., Moretti D., Arnold M., Langhans W., Hurrell R.F. Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats. J Nutr 2004, 134(12):3301-3304.
54. Harvey R.S., Reffitt D.M., Doig L.A., Meenan J., Ellis R.D., Thompson R.P., et al. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther 1998, 12(9):845-848.
55. Michel F.M., Barron V., Torrent J., Morales M.P., Serna C.J., Boily J.F., et al. Ordered ferrimagnetic form of ferrihydrite reveals links among structure, composition, and magnetism. Proc Natl Acad Sci U S A 2010, 107(7):2787-2792.
56. Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex/a review of over 25 years experience. Arzneimittelforschung 2007, 57(6A):439-452.
57. Van Wyck D.B., Martens M.G., Seid M.H., Baker J.B., Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007, 110(2 Pt 1):267-278.
58. Lane R.S. Intravenous infusion of iron-dextran complex for iron-deficiency anaemia. Lancet 1964, 1(7338):852-854.
59. Bisbe E., Garcia-Erce J.A., Diez-Lobo A.I., Munoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011, 107(3):477-478.
60. Lindgren S., Wikman O., Befrits R., Blom H., Eriksson A., Granno C., et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 44(7):838-845.
61. Eusterhues K., Wagner F.E., Hausler W., Hanzlik M., Knicker H., Totsche K.U., et al. Characterization of ferrihydrite-soil organic matter coprecipitates by X-ray diffraction and Mossbauer spectroscopy. Environ Sci Technol 2008, 42(21):7891-7897.
62. Mikutta C. X-ray absorption spectroscopy study on the effect of hydroxybenzoic acids on the formation and structure of ferrihydrite. Geochim Cosmochim Ac 2011, 75(18):5122-5139.
63. Latunde-Dada G.O., Simpson R.J., McKie A.T. Duodenal cytochrome B expression stimulates iron uptake by human intestinal epithelial cells. J Nutr 2008, 138(6):991-995.
64. Raja K.B., Simpson R.J., Peters T.J. Investigation of a role for reduction in ferric iron uptake by mouse duodenum. Biochim Biophys Acta 1992, 1135(2):141-146.
65. Raja K.B., Pountney D., Bomford A., Przemioslo R., Sherman D., Simpson R.J., et al. A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis. Gut 1996, 38(5):765-769.
66. Wollenberg P., Rummel W. Dependence of intestinal iron absorption on the valency state of iron. Naunyn Schmiedebergs Arch Pharmacol 1987, 336(5):578-582.
67. Pereira D.I., Mergler B.I., Faria N., Bruggraber S.F., Aslam M.F., Poots L.K., et al. Caco-2 cell acquisition of dietary iron(III) invokes a nanoparticulate endocytic pathway. PLoS One 2013, 8(11):e81250.
68. Chasteen N.D., Harrison P.M. Mineralization in ferritin: an efficient means of iron storage. J Struct Biol 1999, 126(3):182-194.
69. Barron V., Torrent J., de Grave E. Hydromaghemite, an intermediate in the hydrothermal transformation of 2-line ferrihydrite into hematite. Am Mineral 2003, 88(11-12):1679-1688.
70. Deller D.J., Edwards R.G., Dart G., Luke C.G., Davis P.S. Gastric iron binding substance (gastroferrin) in a family with haemochromatosis. Australas Aann Med 1969, 18(1):36-42.
71. Rudzki Z., Baker R.J., Deller D.J. The iron-binding glycoprotein of human gastric juice. II. Nature of the interaction of the glycoprotein with iron. Digestion 1973, 8(1):53-67.
72. San Martin C.D., Garri C., Pizarro F., Walter T., Theil E.C., Nunez M.T. Caco-2 intestinal epithelial cells absorb soybean ferritin by mu(2) (AP2)-dependent endocytosis. J Nutr 2008, 138(4):659-666.
73. Hilty F.M., Arnold M., Hilbe M., Teleki A., Knijnenburg J.T., Ehrensperger F., et al. Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation. Nat Nanotechnol 2010, 5(5):374-380.